Litigation

Recent Posts

Divided 8th Circuit Panel Readmits Plaintiff Expert On Short-Term Prempro Risk
Posted on 27 Jul 2012 by Tom Moylan

ST. LOUIS - (Mealey's) In a 2-1 ruling July 26, the Eighth Circuit U.S. Court of Appeals reversed summary judgment in two Prempro bellwether cases that involve the risk of breast cancer in women who took the hormone replacement therapy drug for less... Read More

Supreme Court Denies Pfizer Certiorari In Trovan Experiment Case
Posted on 29 Jun 2010 by Tom Moylan

WASHINGTON, D.C. - (Mealey's) The U.S. Supreme Court on June 29 rejected Pfizer Inc.'s petition for a writ of certiorari involving the claims of Nigerians allegedly injured during a 1996 Trovan clinical trial in their country, allowing the claims... Read More

$4 Million In Compensatory Damages Awarded By Connecticut Jury In Prempro Breast Cancer Trial
Posted on 19 Apr 2012 by Tom Moylan

NEW HAVEN, Conn. - (Mealey's) A Connecticut federal jury on April 18 awarded a plaintiff and her husband $4 million in compensatory damages after finding that the hormone replacement therapy drug Prempro caused the plaintiff's breast cancer (... Read More

2nd Circuit Sends N.J. Whistle-Blower Claims Of Ex-Pfizer Executive Back For Reconsideration
Posted on 18 Nov 2010 by Tom Moylan

NEW YORK -- (Mealey's) A Second Circuit U.S. Court of Appeals panel on Nov. 17 affirmed summary judgment on federal False Claims Act (FCA) termination claims by former Pfizer executive Peter Rost but reversed judgment as to his claims under New Jersey's... Read More

Pennsylvania Jury Finds Prempro Did Not Cause Women's Breast Cancers
Posted on 18 Aug 2010 by Shane Dilworth

PHILADELPHIA - (Mealey's) A Pennsylvania Common Pleas Court jury on Aug. 18 decided that two women's use of Wyeth's Prempro did not cause them to develop breast cancer and that the maker of the hormone replacement therapy should not be required... Read More

Wisconsin Supreme Court Affirms $13.5 Million Drug Pricing Verdict Against Pharmacia Corp.
Posted on 25 Jun 2012 by Tom Moylan

MADISON, Wis. - (Mealey's) The Wisconsin Supreme Court on June 22 affirmed a $13.5 million verdict and judgment against Pharmacia Corp. for reporting inflated drug prices and causing the state Medicaid program to overpay, an appeal that stayed the... Read More

Pa. Supreme Court Says Drug Companies Can Be Sued For Marketing Dangerous Drugs
Posted on 23 Jan 2014 by Tom Moylan

PHILADELPHIA — (Mealey’s) Pennsylvania law allows drug companies to be sued if they fail to stop marketing drugs known to be unreasonably harmful, and the manufacturers are not immune from being sued for damages for lack of due care, the Pennsylvania... Read More

Conn. Federal Judge Awards $1.7 Million In Punitive Damages In Prempro Breast Cancer Case
Posted on 5 Aug 2013 by Tom Moylan

NEW HAVEN, Conn. — (Mealey’s) Applying Connecticut law governing punitive damages in product liability actions, a Connecticut federal judge on Aug. 5 awarded $1,769,932 to a woman and her husband, who in April 2012 were awarded $4 million... Read More

Wyeth Wins 4th Prempro MDL Bellwether Trial
Posted on 20 Oct 2010 by Tom Moylan

JONESBORO, Ark. - (Mealey's) An Arkansas federal jury on Oct. 19 said a plaintiff did not prove that Wyeth inadequately warned her and her doctor that the hormone replacement therapy drug Prempro could cause breast cancer ( In re: Prempro Products... Read More

Neurontin MDL Judge Grants Summary Judgment Against All But 2 Class Plaintiffs
Posted on 10 Dec 2010 by Tom Moylan

BOSTON - (Mealey's) The Massachusetts federal judge overseeing the Neurontin multidistrict litigation on Dec. 10 granted summary judgment against all but two class action plaintiffs after finding no direct evidence that Pfizer Inc.'s off-label... Read More

Go-It-Alone Whistle-Blowers Force $14.5M Pfizer Settlement For Off-Label Promotion
Posted on 21 Oct 2011 by Tom Moylan

BOSTON - (Mealey's) Two whistle-blowers who went it alone in prosecuting a False Claims Act lawsuit against Pfizer Inc. in a Massachusetts federal court have forced a $14.5 million settlement for the off-label marketing of Detrol, according to announcements... Read More

Pa. High Court Reconsiders, Won’t Disturb $8.6M Prempro Punitive Damages Award
Posted on 17 Dec 2013 by Tom Moylan

PHILADELPHIA — (Mealey’s) The Pennsylvania Supreme Court on Dec. 16 let stand an $8.6 million punitive damages verdict in a Prempro hormone replacement therapy case after dismissing the appeal as improvidently granted ( Mary Daniel, et al... Read More

Duane Morris Alert: Big Win For Drug Companies Under The New Jersey Product Liability Act
Posted on 16 Nov 2011 by Duane Morris LLP

On September 29, 2011, in Bailey v. Wyeth, et al. , a New Jersey appellate court affirmed summary judgment in favor of two Pfizer subsidiaries and Wyeth, Inc., dismissing claims for violations of New Jersey's Product Liability Act (PLA). The claims... Read More

Asbestos Claims Against Quigley Parent Pfizer Allowed By 2nd Circuit
Posted on 11 Apr 2012 by Emerson Heffner

NEW YORK - (Mealey's) Personal injury suits seeking to hold Pfizer Inc. liable for asbestos-containing products manufactured by bankrupt subsidiary Quigley Co. Inc. under an "apparent manufacturer" theory of liability are not barred by an... Read More